2026年2月6日，对于所有盯着黄金市场的人来说，注定是个难忘的日子。 前一晚还在为暴跌哀嚎，一 觉醒来却发现行情来了个"回马枪"，手快的或许庆幸，手慢的只剩懊恼，而更多的人则被彻底搞懵了： 这金价，到底唱的哪一出？ 就在2月5日晚上，国际黄金市场还是一片惨淡。 伦敦金现的价格从白天的相对高位一路向下，跌得毫 无阻力，最终单日暴跌超过190美元，收盘价砸到了4815美元/盎司附近，跌幅接近4%。 这种跌幅在近 期的高位震荡中，算得上是一次实实在在的"踩踏"。 国内市场的反应同样迅速。 上海黄金交易所的黄金T D合约，价格跟着国际金价一起跳水，最低探到了 1082元/克左右。 传导到零售端，就是大家最熟悉的金店牌价跟着往下调。 那天晚上，周大福、周大生 这些头部品牌的足金首饰克价，纷纷跌破了1560元关口，老凤祥也回落到了1568元/克。 不少之前在高 位买入，指望着"黄金永远涨"的投资者，心态开始崩了，有些人甚至忍痛割肉离场。 然而，市场的剧本在2月6日清晨被彻底改写。 从凌晨开始，伦敦金现的价格像被一只无形的手猛地托 起，从4815美元附近启动，短短四个小时里，一路狂飙超过160美元，最高冲到了4980美元 ...

Market Overview - The A-share market experienced a collective decline today, with the Shanghai Composite Index falling by 2.48%, the Shenzhen Component Index by 2.69%, and the ChiNext Index by 2.46% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 2.61 trillion yuan, a decrease of 255.8 billion yuan compared to the previous day, with over 4,600 stocks declining [1] Sector Performance - Major sectors such as precious metals, oil and gas extraction and services, chemicals, coal, steel, semiconductors, PEEK materials, and photolithography concept stocks saw significant declines, while the liquor and power grid equipment sectors showed resilience [1] - The precious metals and related sectors were heavily sold off, with stocks like Hunan Silver hitting the limit down with nearly 10 billion yuan in sell orders [1] External Influences - The recent "black swan" event in global commodity markets, particularly the sharp drop in international gold and silver prices, was a direct trigger for today's A-share adjustment [3] - Concerns over the potential hawkish stance of the new Federal Reserve Chair, coupled with significant profit-taking by hedge funds, led to a more than 5% drop in gold prices in a single trading day, marking the largest single-day decline in nearly a decade [3] Domestic Factors - An increase in the value-added tax rate for telecom services from 6% to 9% starting January 1, 2026, is expected to impact the profit forecasts of major telecom operators like China Mobile, China Telecom, and China Unicom, contributing to a decline in their stock prices [4] - The dense disclosure period for annual performance forecasts has led to some companies failing to meet high market expectations, resulting in a collective pullback in growth stocks, particularly in the semiconductor and certain new energy sectors [4] Market Sentiment and Future Outlook - The market is currently facing seasonal liquidity tightening as the Spring Festival approaches, leading some investors to hold cash to avoid uncertainties during the holiday, which has weakened market support [4] - Despite the current downturn, there may be opportunities for short-term rebounds as some risks have been released, and investors are advised to look for quality stocks that have been oversold [5] - The ability of the market to stabilize in the short term will depend on whether gold and silver prices can find a bottom and stabilize [5]

2月4日，随着避险情绪的波动和宏观政策信号的明朗，贵金属市场正经历一场由"超跌反弹"驱动的估值 重塑。金丰来表示，在周二的美国午盘交易中，黄金与白银展现出了极强的韧性，多头资金在经历了前 期的剧烈洗盘后表现出强烈的抄底意愿。受政府拨款法案获批、停摆危机解除的利好提振，金银价格双 双走出阴霾。这种由政策预期改善带动的风险偏好回升，不仅止住了价格的非理性下跌，更在技术层面 上构筑了坚实的短期底部。 外部因素共振与数据真空期的机遇 除了政坛局势的明朗化，汇市与能化市场的走势也为金银价格的飙升提供了燃料。事实数据表示，美元 指数近期走势疲软，而原油价格稳定在每桶62.75美元附近，这对作为抗通胀资产的贵金属而言是明确 的利多信号。金丰来认为，由于政府停摆导致1月非农报告等关键经济数据延期发布，市场进入了一个 短暂的"信息真空期"，这使得资金流向更加依赖技术面引导和突发新闻驱动。在这种环境下，4月黄金 期货单日录得超过300美元的涨幅，收报4959.00美元，显示出实物资产在不确定性中的吸引力。 尽管短期反弹势头迅猛，但中长期的多空博弈依然焦灼。金丰来表示，从日线图来看，黄金此前形成的 看跌反转形态虽暗示顶部可能已经出 ...

Core Viewpoint - The strong performance of China Coal Energy (601898) on February 4, with a 10% increase in stock price, is attributed to multiple factors including business fundamentals, sector sentiment, and a rebound from previous declines [2]. Group 1: Stock Performance - On February 4, China Coal Energy's stock surged to the daily limit, closing at 14.08 yuan, with a total trading volume of 9.55 billion yuan, approximately 2.3 times higher than the previous trading day [1]. - The stock experienced a net inflow of 159.13 million yuan from main funds, indicating strong market interest [1]. Group 2: Business Fundamentals - China Coal Energy's core business includes coal production and trade, coal chemical products, mining equipment manufacturing, pithead power generation, and financial services, with key products being thermal coal, coking coal, polyolefins, urea, and methanol [2]. - The company has a competitive advantage in coal mining, with production costs lower than most coal enterprises in China [2]. - The domestic fertilizer market is experiencing structural price increases, significantly enhancing short-term profitability for the company [2]. Group 3: Future Prospects - The company anticipates an additional production capacity of 6.4 million tons per year for coal and 900,000 tons per year for coal chemicals by the end of 2026 or 2027, which is expected to improve long-term profitability [2]. - Following a 7.38% drop in stock price on February 2, the market pressure was released, allowing for a potential rebound, further amplified by the collective rise in the coal mining sector [2].

历史性暴跌后，贵金属迎来强势修复。 2月3日，黄金、白银同步大幅拉升，悉数收复前一日失地。其中，白银涨势尤为迅猛，涨幅远超黄金， 期现货市场齐头并进。 截至发稿，伦敦金现日内大涨5.56%，报4918.34美元/盎司，盘中最高触及4949.99美元/盎司；伦敦银现 涨势更为迅猛，日内大涨9.87%，报86.94美元/盎司，最高上探至87.954美元/盎司，涨幅依旧远超黄 金。两者均已收复昨日跌幅。 | 伦敦金现 | | | SPTAUUSDOZ | | --- | --- | --- | --- | | 4918.340 | | | +259.062 +5.56% | | IDC USD 17:00:42 | | | 6 | | 卖一 | 4919.440 | | | | 头一 | 4918.340 | | | | 总量 | 0 | 现手 | 0 | | 结算价 | | 开盘 | 4669.080 | | 最高 | 4949.990 | 最低 | 4666.083 | | 均价 | - | 振幅 | 6.09% | | 外盘 | 0 | 内盘 | 0 | | 昨结 | 4659.278 | 品出版 | 465 ...

Core Viewpoint - The international gold and silver futures prices experienced a significant rebound after a period of decline, with gold prices rising above $4900 per ounce and silver prices surpassing $87 per ounce, indicating a recovery in market sentiment [1][2]. Group 1: Market Dynamics - The primary reason for the rebound is identified as a "super dip rebound," following a substantial decline where New York gold saw a maximum pullback of 21.28% and New York silver a maximum pullback of 40.59%, leading to an oversold technical condition [1]. - The reduction in passive liquidation pressure due to previous CME margin increases has allowed for a resurgence of bottom-fishing capital and short covering, resulting in a 45% increase in COMEX gold trading volume and a 62% increase in silver trading volume [1]. Group 2: Supply and Demand Fundamentals - The short-term support for precious metals remains unchanged, with the People's Bank of China increasing gold reserves for 14 consecutive months and global central banks averaging 70 tons of gold purchases monthly, highlighting the growing monetary attributes of precious metals amid de-dollarization [2]. - A projected supply-demand gap of 320 tons for gold in 2026 and an 8% annual growth rate in industrial silver demand, contrasted with a mere 2% increase in mineral supply, indicates a long-term supply shortage [2]. - Ongoing geopolitical tensions in the Middle East and the return of funds to safe-haven assets further support gold and silver prices [2]. Group 3: Market Outlook - In February, the primary precious metal prices are expected to fluctuate within a range, with gold between $4500 and $5100 per ounce and silver between $70 and $85 per ounce, while a gradual upward trend is anticipated in the medium term [3]. - Investors are advised to manage their positions cautiously as the market approaches the Chinese New Year, with recommendations to wait for market stabilization post-holiday before increasing allocations [3].

Market Overview - The market opened at 4043, reached a low of 4002, a high of 4069, and closed at 4067, with a bullish trend as 4856 stocks rose against 532 that fell [1] - Historical patterns indicate that stocks are showing signs of resilience, which is often seen before a market bottom [1] - The closing above 4064 is deemed acceptable, while a close above 4084 would be better, and above 4103 would indicate strong market conditions [1] Technical Analysis - The daily key areas for the major indices are identified, with the market currently positioned between 4096 and 4027, closing above the lower boundary [4] - The short-term technical outlook suggests that the market is in a mixed state, with potential for both upward and downward movements [7][8] - The daily life line is around 4090, and staying above this level is necessary for a bullish outlook [8] Index Performance - The major indices showed varied performance, with the main index closing as a small bullish candle, indicating a potential reversal pattern [7] - The ChiNext index closed with a small bullish candle, suggesting short-term bullish sentiment despite a mid-term bearish outlook [7] Future Projections - The possibility of breaking through the 4190 level before the Spring Festival is considered low, indicating a cautious outlook for the near term [2] - Key resistance and support levels for the indices have been outlined, with significant levels at 4131 for the market and 3368 for the ChiNext index [8]

1月30日，和讯投顾吴青宇表示，周一便提醒大家周四后需警惕黄金白银调整，如今行情如期展开回 调。接下来详细分析黄金白银与A股市场走势：黄金白银此轮上涨始于2024年9月美联储降息周期开 启，本周四凌晨美联储利率决议暂停降息后，黄金在周四晚美盘时段闪崩，印证了周一"周四前是有色 周期商品最后狂欢"的判断。地缘政治因素仅能短期影响金价，需重点关注美联储暂停降息后黄金的调 整周期——按去年12月利率决议点阵图显示，今年或仅两次降息（分别在年中与年末），且需待鲍威尔 卸任后才可能重启降息，时间节点或为五六月份。因此，本轮黄金调整大概率持续至年中，待再次降息 后或创阶段新高，但可能成为近几年大顶；若年底降息后释放2027年无降息预期，黄金将真正见顶。再 看A股市场，今日早盘虽大幅跳水，但"龙队"死守4100点关键位（盘中可破但收盘必须收复），该点位 构成心理支撑。不过，年前行情仍以震荡为主，预计呈现"涨一天跌一天"格局，有色板块回调后涨价逻 辑暂告段落，年前炒作或聚焦超跌反弹品种。年后资金大概率回流商业航天及AI相关的软硬件领域。 ...

今天有三个不相信，第一个是沪金主力一天可以涨7.88%，这可是商品期货，带杠杆的，而且此前已经有不少的涨幅，有人说这种加速是对手盘被动止损产 生的反向回补，但情况是这玩儿是国际定价，并不是我们黄金市场限制交易就能理解的，国外黄金涨了你不跟着涨？所以黄金已经看不懂。有研究员说，顺 周期涨价顺序是黄金—白银—基础金属—石油—化工—农业，里面没有黑色金属，因为黑色金属并不是国际定价，大家真要看好顺周期别往钢铁潜伏就行， 其它的看运气。 第二个是白酒，今天板块涨幅9.68%，白酒昨天还在创历史新低，突然来了一根这么大的阳线，你说是超跌反弹也行，你说是行业拐点也行，反正短周期趋 势被打断，就算再创新低，估计两周内不可能出现了，然后不少踏空的开始酸白酒踏空，我觉得没有必要，除非你昨天真的感觉白酒要启动，否则今年持有 白酒，依旧是亏损的，更别说是一直持有的。 第三个是大佬改游戏规则了，十点没有砸盘，涨0.5%也没有砸盘，而是横盘，成交量最大的时候砸盘，可能大家都被这个节奏吓坏了，于是今天是本周第 四天3000+待涨的情况，而且上证50，沪深300涨幅超过0.5%，可指数没涨，所以中小盘成为代价，现在开始精准打击题材，但筹码 ...

Core Viewpoint - The significant rebound in Zhifei Biological's stock price, with a rise of 14.87% on January 26, is attributed to multiple factors including technical recovery, market sentiment, and concentrated shareholding, despite a backdrop of poor financial forecasts and ongoing operational challenges [1][3][5]. Group 1: Stock Performance - On January 26, Zhifei Biological's stock surged by 14.87%, increasing approximately 2.57 yuan per share, closing around 19.85 yuan, with notable trading activity [1]. - The company's stock price has been on a downward trend for four consecutive years, with a nearly 30% decline in 2025, placing its valuation at historical lows [1][5]. Group 2: Financial Forecast and Market Reaction - On January 12, the company announced a projected annual loss of 10.698 billion to 13.726 billion yuan for 2025, representing a year-on-year decline of 630% to 780%, primarily due to excess inventory of the nine-valent HPV vaccine and a significant drop in agency business revenue [3]. - Concerns were raised regarding the company's inventory balance exceeding 20.2 billion yuan, with risks of the nine-valent HPV vaccine nearing expiration and evident pressure on the cash flow [3]. Group 3: Market Sentiment and Shareholding Dynamics - The stock price surge was influenced by a reduction in the number of shareholders to 121,000, a decrease of 1,917 (1.56%), indicating increased concentration of shares as retail investors exited [3][5]. - Market speculation suggested that the inventory of the nine-valent HPV vaccine was being consumed faster than expected, although this information was not officially confirmed by the company [3]. Group 4: Divergent Market Opinions - The bullish sentiment among investors highlighted technical and emotional recovery, with some believing the stock had entered an upward trend after breaking above the 60-day moving average [4]. - Conversely, bearish opinions questioned the sustainability of the rally, citing unresolved issues such as high inventory levels and reliance on agency business, suggesting a likely correction in the future [4]. Group 5: Driving Factors Behind Stock Movement - The stock's rebound can be attributed to four main factors: significant technical recovery due to prolonged declines, market expectations of exhausted negative news following the earnings forecast, increased shareholding concentration facilitating price increases, and positive sentiment in the broader pharmaceutical sector [5].